全球糖尿病監測設備市場

預計到 2030 年全球糖尿病監測設備市場規模將達 175 億美元

全球糖尿病監測設備市場規模預計在2024年為121億美元，到2030年將達到175億美元，在2024-2030年的分析期間內，複合年成長率為6.4%。自我血糖監測設備是本報告分析的細分市場之一，預計其複合年成長率為5.2%，到分析期結束時規模將達到110億美元。持續血糖監測設備細分市場在分析期間的複合年成長率預計為8.7%。

美國市場規模將達 33 億美元；中國市場複合年成長率將達 9.8%

美國糖尿病監測設備市場規模預計2024年達到33億美元。作為世界第二大經濟體，中國市場規模預計將在2030年達到36億美元，在分析期間（2024-2030年）的複合年成長率為9.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為3.2%和6.2%。在歐洲，德國的複合年成長率預計為4.2%。

全球糖尿病監測設備市場－主要趨勢與促進因素摘要

為什麼糖尿病監測設備在現代疾病管理中很重要？

糖尿病是全球最常見的慢性疾病之一，糖尿病監測設備已成為管理糖尿病的關鍵，它能為患者和醫護人員提供即時血糖值資訊，並幫助他們更好地制定治療方案。糖尿病影響全球超過5億人，由於久坐不動的生活方式、不良飲食習慣和人口老化，預計患病人數還會迅速增加，因此對精準、便捷、持續血糖監測的需求比以往任何時候都更加迫切。這些設備透過維持血糖控制，在預防心血管疾病、神經病變、腎衰竭和視力喪失等併發症方面發揮關鍵作用。雖然血糖儀 (BGM) 等傳統設備因其價格實惠、操作簡便而仍然被廣泛使用，但持續血糖監測 (CGM) 系統和閃光血糖監測儀正逐漸獲得優勢，因為它們無需紮手指即可提供每分鐘的血糖更新。透過整合藍牙和無線連接，這些工具正在轉型成為智慧型設備，可與應用程式同步、支援雲端資料儲存並提供即時警報，從而賦予患者更大的自主權。此外，隨著醫療保健系統越來越關注家庭慢性病管理，糖尿病監測設備對於個人護理和更廣泛的公共衛生結果都變得至關重要。

科技如何徹底改變糖尿病監測設備的功能？

技術創新正在再形成糖尿病監測格局，推動設備準確性、易用性以及與整體數位健康生態系統的融合。如今，連續血糖監測儀 (CGM) 可提供長達兩週的感測器佩戴、即時追蹤和預測警報，以警告即將發生的低血糖或高血糖事件。生物感測材料和酵素技術的進步正在提高讀數的準確性，同時最大限度地減少皮膚刺激和校準需求。穿戴式裝置正變得越來越小、越來越隱密、越來越非侵入性，並且正在研究使用紅外光譜和汗液分析進行無針血糖監測。智慧型手機整合允許用戶記錄飲食、藥物和運動情況以及血糖讀數，人工智慧主導的平台可以分析這些變數以提供個人化建議。雲端基礎的平台促進了與臨床醫生的數據共用，從而實現遠端監測、早期療育和減少就診次數。閉合迴路胰島素輸送系統（也稱為人工胰臟技術）將胰島素幫浦與 CGM 結合，可根據即時血糖數據自動輸送胰島素。這些技術創新不僅提升了便利性和舒適性，也顯著改善了第1型和第2型糖尿病患者的治療效果。隨著數位健康與穿戴式裝置的融合，糖尿病監測正在演變成一種智慧、預測性和互聯互通的照護模式。

為什麼患者賦權和生活方式融合將推動設備的採用？

以患者為中心的照護和以生活方式為基礎的疾病管理模式的轉變是推動先進糖尿病監測設備普及的主要驅動力。現代患者不再是照護的被動接受者，而是積極的參與者，他們期望工具能夠無縫融入日常生活，同時提供清晰的見解和可操作的數據。能夠輕鬆融入日常生活的設備，例如可與智慧型手錶和健身追蹤器通訊的動態血糖監測 (CGM)，正日益受到青睞，尤其是在科技達人和年輕群體中。即時血糖數據的心理影響也能鼓勵人們堅持飲食建議、運動習慣和用藥計畫。對於運動員、忙碌的專業人士以及照顧糖尿病兒童的看護者來說，遠端警報和趨勢圖等功能可以讓他們安心，並增強對病情的管理。許多此類設備現在支援多語言介面、語音助理和教育功能，以促進對疾病機制和自我護理實踐的理解。便捷且價格合理的設備正在被引入，以改善醫療資源匱乏人口的醫療服務可近性和健康公平性。隨著糖尿病認知度的提高和恥辱感的減少，監測設備擴大被視為日常健康夥伴，而非臨床工具。這種觀念的轉變正在鼓勵人們更參與並長期堅持，而這正是成功控制血糖和減輕糖尿病相關併發症整體負擔的關鍵因素。

推動全球糖尿病監測設備市場成長的關鍵因素有哪些？

糖尿病監測設備市場的成長受到人口、技術、政策和行為等多種因素的共同驅動，這些因素共同推動了人們對更精準的疾病追蹤和個人化照護的重視。全球糖尿病盛行率的上升是主要促進因素，尤其是在新興國家，都市化、加工食品消費和遺傳因素導致新增確診病例激增。同時，已開發國家正經歷人口老化，這增加了對慢性病管理工具的需求。政府舉措和醫療改革透過補貼血糖監測設備、擴大報銷範圍和開展公眾意識宣傳活動發揮支持作用。疫情加速了人們對預防保健和遠端監測的重視，使穿戴式血糖監測儀成為虛擬護理策略的核心。科技公司和醫療保健提供者之間的夥伴關係也正在建立一個更一體化的生態系統，將穿戴式裝置、電子健康記錄 (EHR) 和人工智慧 (AI) 分析相結合，以實現全面的糖尿病管理。消費者對微創和用戶友善設備的偏好正在影響研發工作，並推動製造商在設計和功能方面進行創新。此外，主要產業參與者向亞太地區、拉丁美洲和中東地區的戰略擴張正在為其成長鋪平新的道路。隨著技術的成熟和全球健康重點轉向主動護理，糖尿病監測設備有望成為管理這種普遍疾病的基礎工具。

部分

產品類型（自我監測、持續血糖監測）；適應症（1 型糖尿病、2 型糖尿病、妊娠糖尿病）；最終用戶（醫院、診所、居家醫療機構、其他最終用戶）

受訪公司範例（總合42家公司）

• Abbott Laboratories
• AgaMatrix
• Arkray, Inc.
• Ascensia Diabetes Care
• B. Braun Melsungen AG
• Bayer AG
• Dexcom, Inc.
• F. Hoffmann-La Roche Ltd
• Insulet Corporation
• i-SENS, Inc.
• Johnson & Johnson Services, Inc.
• LifeScan, Inc.
• Medtronic plc
• Novo Nordisk A/S
• Roche Diabetes Care
• Sanofi
• Senseonics Holdings, Inc.
• Tandem Diabetes Care, Inc.
• Valeritas Holdings, Inc.
• Ypsomed Holding AG

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）來預測其競爭地位的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 比賽

Global Diabetes Monitoring Devices Market to Reach US$17.5 Billion by 2030

The global market for Diabetes Monitoring Devices estimated at US$12.1 Billion in the year 2024, is expected to reach US$17.5 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Self-Monitoring Blood Glucose Devices, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$11.0 Billion by the end of the analysis period. Growth in the Continuous Glucose Monitoring Devices segment is estimated at 8.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 9.8% CAGR

The Diabetes Monitoring Devices market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Diabetes Monitoring Devices Market - Key Trends & Drivers Summarized

Why Are Diabetes Monitoring Devices Crucial in Modern Disease Management?

Diabetes monitoring devices have become indispensable in the management of one of the world’s most prevalent chronic diseases, offering patients and healthcare providers real-time insights into blood glucose levels and enabling better decision-making in treatment plans. With diabetes affecting over 500 million people globally and projections indicating a rapid rise due to sedentary lifestyles, poor dietary habits, and aging populations, the need for precise, accessible, and continuous glucose monitoring has never been greater. These devices play a pivotal role in preventing complications such as cardiovascular disease, neuropathy, kidney failure, and vision loss by helping maintain glycemic control. Traditional devices like blood glucose meters (BGMs) remain widely used for their affordability and simplicity, but continuous glucose monitoring (CGM) systems and flash glucose monitors are gaining dominance for their ability to provide minute-by-minute updates without the need for finger pricks. The integration of Bluetooth and wireless connectivity has transformed these tools into smart devices that sync with apps, allow for cloud data storage, and offer real-time alerts, empowering patients with greater autonomy. Additionally, healthcare systems are increasingly emphasizing home-based chronic disease management, making diabetes monitoring devices essential to both individual care and broader public health outcomes.

How Is Technology Revolutionizing the Functionality of Diabetes Monitoring Devices?

Technological innovation is reshaping the diabetes monitoring landscape, driving improvements in device accuracy, usability, and integration into holistic digital health ecosystems. Continuous glucose monitors (CGMs) now offer sensor wear times of up to two weeks, with real-time tracking and predictive alerts that warn of impending hypo- or hyperglycemic events. Advances in biosensing materials and enzymatic technology have increased the precision of readings while minimizing skin irritation and calibration needs. Wearable devices are becoming smaller, more discreet, and non-invasive, with research underway for needle-free glucose monitoring using infrared spectroscopy and sweat analysis. Smartphone integration enables users to log meals, medications, and exercise alongside glucose readings, while AI-driven platforms analyze these variables to deliver personalized recommendations. Cloud-based platforms facilitate data sharing with clinicians, allowing for remote monitoring, early intervention, and reduced in-person visits-an advantage magnified during the COVID-19 pandemic. Closed-loop insulin delivery systems, often referred to as artificial pancreas technologies, are combining insulin pumps and CGMs to automate insulin delivery based on real-time glucose data. These innovations are not just enhancing convenience and comfort but are also dramatically improving outcomes for both type 1 and type 2 diabetes patients. As digital health and wearables converge, diabetes monitoring is evolving into a smart, predictive, and connected care paradigm.

Why Is Patient Empowerment and Lifestyle Integration Driving Device Adoption?

The shift toward patient-centered care and lifestyle-based disease management is significantly boosting the adoption of advanced diabetes monitoring devices. Modern patients are no longer passive recipients of care but active participants who expect tools that fit seamlessly into their daily lives while offering clear insights and actionable data. Devices that integrate easily into routine activities-like CGMs that communicate with smartwatches or fitness trackers-are gaining favor, particularly among tech-savvy users and younger demographics. The psychological impact of real-time glucose data also encourages better adherence to dietary recommendations, exercise routines, and medication schedules. For athletes, busy professionals, or caregivers managing children with diabetes, features like remote alerts and trend graphs provide peace of mind and enhanced situational control. Many of these devices now support multilingual interfaces, voice assistants, and educational features that promote understanding of disease mechanics and self-care practices. In underserved populations, simplified and affordable models are being introduced to improve access and health equity. As awareness of diabetes grows and stigma decreases, monitoring devices are increasingly viewed not as clinical tools but as everyday wellness companions. This shift in perception is fostering higher engagement and long-term commitment, critical factors in achieving successful glycemic control and reducing the overall burden of diabetes-related complications.

What Are the Key Drivers Powering Global Growth in the Diabetes Monitoring Devices Market?

The growth in the diabetes monitoring devices market is driven by a confluence of demographic, technological, policy, and behavioral factors that collectively emphasize better disease tracking and personalized care. A major driver is the escalating global prevalence of diabetes, particularly in emerging economies where urbanization, processed food consumption, and genetic predispositions are fueling a surge in new diagnoses. Simultaneously, aging populations in developed nations are contributing to increased demand for chronic disease management tools. Government initiatives and healthcare reforms are playing a supportive role by subsidizing glucose monitoring devices, expanding reimbursement coverage, and launching public awareness campaigns. The growing emphasis on preventive healthcare and remote monitoring-accelerated by the pandemic-has placed wearable glucose monitors at the center of virtual care strategies. Partnerships between tech companies and healthcare providers are also creating more integrated ecosystems, combining wearables, EHRs, and AI analytics for comprehensive diabetes management. Consumer preference for minimally invasive and user-friendly devices is shaping R&D efforts, pushing manufacturers toward innovation in design and functionality. Furthermore, strategic expansion by key industry players into Asia-Pacific, Latin America, and the Middle East is opening new growth avenues. As technology matures and global health priorities shift toward proactive care, diabetes monitoring devices are set to become foundational tools in managing this pervasive disease.

SCOPE OF STUDY:

The report analyzes the Diabetes Monitoring Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices); Indication (Type-I Diabetes, Type-II Diabetes, Gestational Diabetes); End-User (Hospitals, Clinics, Home Care Settings, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• AgaMatrix
• Arkray, Inc.
• Ascensia Diabetes Care
• B. Braun Melsungen AG
• Bayer AG
• Dexcom, Inc.
• F. Hoffmann-La Roche Ltd
• Insulet Corporation
• i-SENS, Inc.
• Johnson & Johnson Services, Inc.
• LifeScan, Inc.
• Medtronic plc
• Novo Nordisk A/S
• Roche Diabetes Care
• Sanofi
• Senseonics Holdings, Inc.
• Tandem Diabetes Care, Inc.
• Valeritas Holdings, Inc.
• Ypsomed Holding AG

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Diabetes Monitoring Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Global Diabetes Epidemic Throws the Spotlight on Continuous Glucose Monitoring (CGM) Systems
  • Shift Toward Non-Invasive Monitoring Technologies Fuels R&D in Next-Generation Sensor Innovation
  • Growth in Wearable and App-Based Glucose Trackers Accelerates Patient Engagement and Real-Time Monitoring
  • Rising Demand for Personalized Diabetes Management Strengthens Use of Integrated CGM-Insulin Delivery Systems
  • Push Toward Value-Based Care Models Supports Use of Remote Glucose Monitoring in Chronic Disease Programs
  • Expansion of Type 2 Diabetes Screening in Emerging Markets Increases Demand for Affordable Glucometers
  • Adoption of AI and Predictive Analytics in Glucose Data Supports Real-Time Hypo/Hyperglycemia Alerts
  • Growth of Pediatric Diabetes Management Drives Need for Child-Friendly, Low-Burden Monitoring Tools
  • Increased Use of CGM in Gestational Diabetes Management Expands Clinical Application Range
  • Integration with EHR and Telehealth Services Enables Endocrinologist-Patient Collaboration
  • Consumer Preference for Discreet, Pain-Free Devices Propels Innovation in Skin-Adhesive Patch Monitors
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Diabetes Monitoring Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Diabetes Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Self-Monitoring Blood Glucose Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Self-Monitoring Blood Glucose Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Self-Monitoring Blood Glucose Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Continuous Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Continuous Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Type-I Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Type-I Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Type-I Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Type-II Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Type-II Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Type-II Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Gestational Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Gestational Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Gestational Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• JAPAN
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• CHINA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• EUROPE
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Diabetes Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• FRANCE
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• GERMANY
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Diabetes Monitoring Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• INDIA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Diabetes Monitoring Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Diabetes Monitoring Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Diabetes Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030
• AFRICA
  • Diabetes Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Diabetes Monitoring Devices by Product Type - Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Diabetes Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Diabetes Monitoring Devices by Indication - Type-I Diabetes, Type-II Diabetes and Gestational Diabetes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Diabetes Monitoring Devices by Indication - Percentage Breakdown of Value Sales for Type-I Diabetes, Type-II Diabetes and Gestational Diabetes for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Diabetes Monitoring Devices by End-user - Hospitals, Clinics, Home Care Settings and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Diabetes Monitoring Devices by End-user - Percentage Breakdown of Value Sales for Hospitals, Clinics, Home Care Settings and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION